GlobalData analyst Dr Andrew S Thompson’s states Medtronic could significantly grow Scientia’s micro guidewire franchise if they can replicate its US success on the international stage.
Medtronic has agreed to acquire Scientia Vascular in a $550m deal positioned to advance the company’s international presence in the neurovascular guidewire market.
Under the agreement, which holds the potential for undisclosed earn-out and milestone payments post-acquisition, Medtronic will inherit the Utah-based company’s portfolio of access microcatheters and micro guidewires.
Scientia’s products are used in navigating cerebral vasculature associated with the treatment of various neurovascular conditions. Medtronic anticipates that the products will enable “faster and more reliable” access during treatment procedures for conditions such as acute ischemic stroke.
Linnea Burman, senior vice president and president of Medtronic’s neurovascular business, commented: “This acquisition positions Medtronic with a full suite of products. It builds a strong foundation for Medtronic and supports procedures across both haemorrhagic and acute ischemic stroke.”
Scientia’s CEO, Rick Randall, stated that its acquisition by Medtronic would allow the company to take its engineering “into disease states globally”.
GlobalData analysis reveals that the global interventional neuroradiology market, which includes neurovascular products such as micro guidewires, is growing at a CAGR of 8.6% and projected to reach a valuation of around $9.8bn in 2035, up from $4.3bn in 2025.
Source: https://www.medicaldevice-network.com/news/medtronic-to-strengthen-neurovascular-business-with-550m-scientia-vascular-acquisition/?cf-view